Cyclophosphamide, cisplatin, and carmustine: pharmacokinetics of carmustine following multiple alkylating-agent interactions (Q72875635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Cyclophosphamide, cisplatin, and carmustine: pharmacokinetics of carmustine following multiple alkylating-agent interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

1 reference

R B Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Matthes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

D Kemme

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

C Dufton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Kernan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

59-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics and immediate effects of high-dose carmustine in man

30 October 2019

cites work

1 reference

12 December 2020

The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyU-l-nitrosourea (BCNU) in man and animals

1 reference

12 December 2020

Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide

1 reference

12 December 2020

Mechanisms of cyclophosphamide action on hepatic P-450 expression

1 reference

12 December 2020

Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study

1 reference

12 December 2020

The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the pl

1 reference

12 December 2020

Involvement of FMN and phenobarbital cytochrome P-450 in stimulating a one-electron reductive denitrosation of 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea catalyzed by NADPH-cytochrome P-450 reductase

1 reference

12 December 2020

Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine

1 reference

12 December 2020

A chemical basis for the antitumor activity of chloroethylnitrosoureas

1 reference

12 December 2020

Microsomal metabolism of nitrosoureas

1 reference

12 December 2020

Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion

1 reference

12 December 2020

Potential roles for preclinical pharmacology in phase I clinical trials

1 reference

12 December 2020

Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats

1 reference

12 December 2020

High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.

1 reference

12 December 2020

Glutathione-dependent denitrosation of N,N'-bis(2-chloroethyl)N-nitrosourea (BCNU): nitrite release catalyzed by mouse liver cytosol in vitro

1 reference

12 December 2020

Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stag

1 reference

12 December 2020

Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells

1 reference

12 December 2020

Mechanism of Hydrolysis of Halogenated Nitrosoureas

1 reference

12 December 2020

Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.

1 reference

12 December 2020

Drug precipitation within i.v. tubing: a potential hazard of chemotherapy administration

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7987978%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference